AM
Healthcare & Life Sciences
Amipharm
South Koreawww.amipharm.com/
Amipharm is a Healthcare & Life Sciences startup based in South Korea, 1 tracked investor.
Active
1
Investors
About Amipharm
Amipharm is a company headquartered in South Korea. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Amipharm develops an injectable medication using polyene phosphatidylcholine extracted from soybeans that induces apoptosis and lipolysis in fat cells for safe, localized fat reduction, particularly targeting submental fat.
Explore Amipharm's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.